|Last Price||Today's Change||52-Week Range||Trading Volume|
|78.70||3.18 (+4.21%)||70.39 - 255.43||157.7 thousand (Below Avg)|
Market data as of 1:37PM 10/09/15. Quotes are delayed by at least 15 min.
Puma Biotechnology Announces Presentation of Phase III Trial of PB272 in Extended Adjuvant Breast Cancer (ExteNET Trial) in Centrally Confirmed HER2-Positive Early Stage Breast Cancer Patients
09/26/2015 4:20 PM ET
Puma Biotechnology Reports Second Quarter 2015 Financial Results
08/10/2015 4:07 PM ET